Europe Platelet Rich Plasma Market, Product Type, By Origin, By Application, and By Country - Size, Share, Outlook, and Opportunity Analysis, 2023

Description

Platelet-rich plasma consists of two elements: plasma, or the liquid portion of blood, and platelets, a type of blood cell that plays an important role in healing throughout the body. Platelets are well-known for their clotting abilities, but they also contain growth factors that can trigger cell reproduction and stimulate tissue regeneration or healing in the treated area. Platelet-rich plasma is simply blood that contains more platelets than normal. Autologous platelet-rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient's own blood. PRP is injected directly at the site of inflamed tissue releasing growth factor which stimulates and increases number of reparative cell in patient body. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. PRP is used for treatment of injured tendons, ligaments, muscles and joints Increasing prevalence of musculoskeletal injuries along with increasing prevalence of knee osteoarthritis is expected to boost growth of Europe platelet-rich plasma market over the forecast period.

Market Dynamics

Increasing adoption of organic growth strategies, such as product launch by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, on February 14 2023, Royal Biologics, an orthobiologics & life science company, announced the commercial launch of BIOINCYTE PRFM, a next-generation Platelet Rich Plasma (PRP) system, which converts traditional PRP to Platelet Rich Fibrin Matrix (PRFM) formulations and eliminates extensive contamination of red blood cells & white blood cells during the formulation of PRP.

Key features of the study:

This report provides in-depth analysis of the Europe platelet rich plasma, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the europe platelet rich plasma based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Vivostat A/S, Estar Medical, CosmoFrance Inc., Kelly Harris Aesthetics, Arthrex, Inc., Terumo Corporation, T-Biotechnology Ltd. St., EmCyte Corporation, Johnson & Johnson Private Limited, Zimmer Biomet, PRP Concepts, ADVACARE PHARMA, Isto Biologics, Arthrex, Inc., Stryker, GLOFINN, Medira Ltd, Regen Lab SA, Estar Technologies Ltd.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global platelet rich plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe platelet rich plasma

Detailed Segmentation:

Europe Platelet Rich Plasma Market, By PRP Type:
- Pure-PRP
- Leukocyte-Rich PRP
- Pure Platelet Rich Fibrin
- Others
Europe Platelet Rich Plasma Market, By Origin:
- Autologous
- Allogeneic/Homologues
Europe Platelet Rich Plasma Market, By Application:
- Orthopaedics
- Cosmetic Surgery and Dermatology
- Neurosurgery
- Cardiothoracic Surgery
- General Surgery
- Urology
- Others
Europe Infection Surveillance Market, By Country:
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Middle East
Company Profiles
- Vivostat A/S*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Estar Medical
- CosmoFrance Inc.
- Kelly Harris Aesthetics
- Arthrex, Inc.
- Terumo Corporation
- T-Biotechnology Ltd. St.
- EmCyte Corporation
- Johnson & Johnson Private Limited
- Zimmer Biomet
- PRP Concepts
- ADVACARE PHARMA
- Isto Biologics
- Arthrex, Inc.
- Stryker
- GLOFINN
- Medira Ltd
- Regen Lab SA
- Estar Technologies Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI3346

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By PRP Type
- Market Snapshot, By Origin
- Market Snapshot, By Application
- Market Snapshot, By Country
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER's Analysis
Pricing Analysis (2021)

4. Europe Platelet rich Plasma Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Europe Platelet rich Plasma Market, By PRP Type, 2018 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pure-PRP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Leukocyte-Rich PRP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Pure Platelet Rich Fibrin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Europe Platelet rich Plasma Market, By Origin, 2018 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Allogeneic/Homologues
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Europe Platelet rich Plasma Market, By Application, 2018 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Orthopaedics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Cosmetic Surgery and Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Neurosurgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Cardiothoracic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
General Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Urology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Europe Platelet rich Plasma Market, By Country, 2018 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
U.K.
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Russia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By PRP Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)

9. Competitive Landscape

Vivostat A/S
- Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Estar Medical
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- CosmoFrance Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Kelly Harris Aesthetics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Arthrex, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Terumo Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- T-Biotechnology Ltd. St.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- EmCyte Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Johnson & Johnson Private Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Zimmer Biomet
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- PRP Concepts
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- ADVACARE PHARMA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Isto Biologics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Arthrex, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Stryker
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
- GLOFINN
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
- Medira Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
- Regen Lab SA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
- Estar Technologies Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance

10. Section

Research Methodology
About Us

Europe Platelet Rich Plasma Market, Product Type, By Origin, By Application, and By Country - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030